AIM OF THE STUDY: To determine the optimal mean arterial pressure (MAP) during the early-to-intermediate phase care of comatose survivors of out-of-hospital cardiac arrest (OHCA). METHODS: We identified consecutive comatose survivors of OHCA with an initial shockable rhythm. Using blood pressure-over-time plots, we calculated the area below pre-specified MAP thresholds (ABT; mmHg*hours) during the first 96 h of admission. We used incremental MAP thresholds ranging between 65 and 85 mmHg. Logistic regression analyses were used to examine the association between ABT and clinical outcomes for each MAP threshold and to adjust for age, duration of cardiac arrest, and bystander CPR. The primary outcome was severe neurological dysfunction as defined by a cerebral performance category (CPC) ≥3. RESULTS: We identified 122 consecutive OHCA patients meeting inclusion criteria. The rate of the primary outcome was 33%. There was a significant association between ABT and the rate of the primary outcome when MAP thresholds of 60 (p = 0.01), 65 (p < 0.01), 70 (p < 0.01), 75 (p < 0.01), and 80 mmHg (p < 0.01) were used. This association was lost once a MAP threshold of 85 mmHg was reached (p = 0.63). In the adjusted analysis, the association between ABT and the primary outcome was no longer present when the MAP threshold reached 75 mmHg. CONCLUSIONS: In comatose survivors of OHCA with an initial shockable rhythm, higher ABT is associated with increased rates of severe neurological dysfunction when MAP thresholds <75 mmHg are used. The current findings support the hypothesis that higher MAP targets (≥75 mmHg) may be indicated in this patient population.
AIM OF THE STUDY: To determine the optimal mean arterial pressure (MAP) during the early-to-intermediate phase care of comatose survivors of out-of-hospital cardiac arrest (OHCA). METHODS: We identified consecutive comatose survivors of OHCA with an initial shockable rhythm. Using blood pressure-over-time plots, we calculated the area below pre-specified MAP thresholds (ABT; mmHg*hours) during the first 96 h of admission. We used incremental MAP thresholds ranging between 65 and 85 mmHg. Logistic regression analyses were used to examine the association between ABT and clinical outcomes for each MAP threshold and to adjust for age, duration of cardiac arrest, and bystander CPR. The primary outcome was severe neurological dysfunction as defined by a cerebral performance category (CPC) ≥3. RESULTS: We identified 122 consecutive OHCA patients meeting inclusion criteria. The rate of the primary outcome was 33%. There was a significant association between ABT and the rate of the primary outcome when MAP thresholds of 60 (p = 0.01), 65 (p < 0.01), 70 (p < 0.01), 75 (p < 0.01), and 80 mmHg (p < 0.01) were used. This association was lost once a MAP threshold of 85 mmHg was reached (p = 0.63). In the adjusted analysis, the association between ABT and the primary outcome was no longer present when the MAP threshold reached 75 mmHg. CONCLUSIONS: In comatose survivors of OHCA with an initial shockable rhythm, higher ABT is associated with increased rates of severe neurological dysfunction when MAP thresholds <75 mmHg are used. The current findings support the hypothesis that higher MAP targets (≥75 mmHg) may be indicated in this patient population.
Authors: Melika Hosseini; Robert H Wilson; Christian Crouzet; Arya Amirhekmat; Kevin S Wei; Yama Akbari Journal: Neurotherapeutics Date: 2020-04 Impact factor: 7.620
Authors: Donald E G Griesdale; Mypinder S Sekhon; Michael D Wood; Danilo Cardim; Penelope M A Brasher; Victoria McCredie; Demetrious Sirounis; Denise Foster; Yulia Krasnogolova; Peter Smielewski; Damon C Scales; Philip N Ainslie; David K Menon; J Gordon Boyd; Thalia S Field; Paul Dorian Journal: Crit Care Explor Date: 2020-09-25
Authors: Joachim Düring; Martin Annborn; Josef Dankiewicz; Allison Dupont; Sune Forsberg; Hans Friberg; Karl B Kern; Teresa L May; John McPherson; Nainesh Patel; David B Seder; Pascal Stammet; Kjetil Sunde; Eldar Søreide; Susann Ullén; Niklas Nielsen Journal: Sci Rep Date: 2022-05-18 Impact factor: 4.996
Authors: Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar Journal: Intensive Care Med Date: 2021-03-25 Impact factor: 17.440
Authors: Pekka Jakkula; Ville Pettilä; Markus B Skrifvars; Johanna Hästbacka; Pekka Loisa; Marjaana Tiainen; Erika Wilkman; Jussi Toppila; Talvikki Koskue; Stepani Bendel; Thomas Birkelund; Raili Laru-Sompa; Miia Valkonen; Matti Reinikainen Journal: Intensive Care Med Date: 2018-11-15 Impact factor: 17.440
Authors: Thomas W Johnson; Irfaan A Dar; Kelly L Donohue; Yama Y Xu; Esmeralda Santiago; Olga Selioutski; Mark A Marinescu; Ross K Maddox; Tong Tong Wu; Giovanni Schifitto; Igor Gosev; Regine Choe; Imad R Khan Journal: Front Neurosci Date: 2022-04-11 Impact factor: 4.677
Authors: Ole Broch; Lars Hummitzsch; Jochen Renner; Patrick Meybohm; Martin Albrecht; Peter Rosenthal; Ann-Christine Rosenthal; Markus Steinfath; Berthold Bein; Matthias Gruenewald Journal: Sci Rep Date: 2021-03-05 Impact factor: 4.379
Authors: Johannes Grand; Christian Hassager; Henrik Schmidt; Jacob E Møller; Simon Mølstrøm; Benjamin Nyholm; Jesper Kjaergaard Journal: Resusc Plus Date: 2021-12-10